Results 61 to 70 of about 30,774 (229)

Higher uptake of common adult vaccines in Australian blood donors: An analysis of linked registry data

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Understanding differences in blood donor vaccine uptake is essential for accurately interpreting serosurveillance of vaccine‐preventable diseases and other research using donor samples and/or data. We aimed to assess vaccination uptake in donors and non‐donors.
Surendra Karki, Veronica Hoad, Bette Liu, Marijke Welvaert, Rena Hirani, David O. Irving   +5 more
wiley   +1 more source

Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact

Human Vaccines & Immunotherapeutics
Pertussis resurgence has been documented even in countries with high pediatric vaccine coverage. The proportion of Bordetella pertussis isolates not expressing pertactin (PRN) has increased in several countries where acellular pertussis (aP) vaccines are
Ulrich Heininger, Helena Martini, Jennifer Eeuwijk, Ivana Prokić, Adrienne P. Guignard, Elisa Turriani, Maurine Duchenne, Valérie Berlaimont   +7 more
doaj   +1 more source

Perspectives on Pertussis Prevention

Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Diphtheria Vaccination Coverage and Correlation With Multidimensional Poverty Among Children in Nigeria

Public Health Challenges, Volume 5, Issue 2, June 2026.
Diphtheria vaccination coverage among Nigerian children remains suboptimal (56%). Coverage is significantly lower in Northern states and inversely correlated with multidimensional poverty. Addressing poverty‐related deprivations is essential to improving immunization equity and curbing recurrent diphtheria outbreaks.
Olufemi Olulaja, Rana Jaber
wiley   +1 more source

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice

Vaccines, 2020
Bordetella pertussis whole-cell vaccines (wP) caused a spectacular drop of global pertussis incidence, but since the replacement of wP with acellular pertussis vaccines (aP), pertussis has resurged in developed countries within 7 to 12 years of the ...
Jana Holubová, Ondřej Staněk, Ludmila Brázdilová, Jiří Mašín, Ladislav Bumba, Andrew R. Gorringe, Frances Alexander, Peter Šebo   +7 more
doaj   +1 more source

The Effect of Maternal Pertussis Vaccination on Neonatal Health Outcomes in the Dutch Pregnancy Drug Register

Birth Defects Research, Volume 118, Issue 4, April 2026.
ABSTRACT Background The currently high pertussis‐related morbidity and mortality among infants has led to increased international attention for pertussis vaccination during pregnancy. We studied the safety of maternal pertussis vaccination in the Netherlands with respect to neonatal health. Methods Data from the cohort the Dutch Pregnancy Drug Register
Petra J. Woestenberg, Veronique Y. F. Maas, Maud de Feijter, Leontine van Balveren, Maartje Conijn, Sanne Boetzkes, Anneke J. L. M. Passier, Agnes C. Kant   +7 more
wiley   +1 more source

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.

PLoS ONE, 2018
BackgroundAcellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence.
Ayman Chit, Hossein Zivaripiran, Thomas Shin, Jason K H Lee, Antigona Tomovici, Denis Macina, David R Johnson, Michael D Decker, Jianhong Wu   +8 more
doaj   +1 more source

Microbial Etiology and Antimicrobial Resistance in Pneumonia Among Hospitalized Patients in Kazakhstan: A Systematic Review and Single‐Arm Meta‐Analysis of Prevalence Data

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Pneumonia is an inflammatory condition of the lower respiratory tract, commonly caused by infection and associated with substantial morbidity and healthcare utilization. The burden of pneumonia on healthcare is exacerbated by limited data on pathogenic causes and associated antimicrobial resistance (AMR). Here, we conducted
Radmir Sarsenov, Maxim Solomadin, Alyona Lavrinenko, Vyacheslav Beloussov, Vitaliy Strochkov, Shynggys Orkara, Nurlan Sandybayev, Sergey Yegorov   +7 more
wiley   +1 more source

Pertussis vaccine. [PDF]

BMJ, 1981
  +7 more sources

Maternal RSV vaccination for infant protection: A systematic review and meta‐analysis of phase 3 trials with an integrated economic evaluation

International Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 63-73, April 2026.
Abstract Background Respiratory syncytial virus (RSV) is a leading cause of hospitalization and mortality in early infancy. Maternal immunization offers a preventive strategy, but uncertainties regarding safety and economic value have limited its implementation.
Johnatan Torres‐Torres, Lourdes Rojas‐Zepeda, José Rafael Villafan‐Bernal, Raigam Martinez‐Portilla, Salvador Espino‐y‐Sosa, Pablo Cerda‐Flores, Elsa Romelia Moreno‐Verduzco, Irma Eloisa Monroy‐Muñoz, Ameyran Yolanda Gonzalez‐Guerrero, Juan Mario Solis‐Paredes, Javier Perez Duran   +10 more
wiley   +1 more source